Browse > Article

Streptochlorin, a Marine Natural Product, Inhibits $NF-{\kappa}B$ Activation and Suppresses Angiogenesis In Vitro  

Choi, In-Kwon (Chemical Genomics Laboratory, Department of Biotechnology, College of Engineering, Yonsei University)
Shin, Hee-Jae (Marine Natural Product Chemistry Laboratory, Ocean Research and Development Institute)
Lee, Hyi-Seung (Marine Natural Product Chemistry Laboratory, Ocean Research and Development Institute)
Kwon, Ho-Jeong (Chemical Genomics Laboratory, Department of Biotechnology, College of Engineering, Yonsei University)
Publication Information
Journal of Microbiology and Biotechnology / v.17, no.8, 2007 , pp. 1338-1343 More about this Journal
Abstract
Angiogenesis is an essential step in tumor progress and metastasis. Accordingly, small molecules that inhibit angiogenesis would appear to be a promising way to cure angiogenesis-related diseases, including cancer. In the present study, we report that streptochlorin, a small molecule from marine actinomycete, exhibits a potent antiangiogenic activity. The compound potently inhibited endothelial cell invasion and tube formation stimulated with vascular endothelial cell growth factor (VEGF) at low micromolar concentrations where it showed no cytotoxicity to the cells. In addition, streptochlorin inhibited TNF-${\alpha}$-induced $NF-{\kappa}B$ activation in the newly developed cell-based reporter gene assay. These data demonstrate that streptochlorin is a new inhibitor of $NF-{\kappa}B$ activation and can be a basis for the development of novel anti-angiogenic agents.
Keywords
Antiangiogenic agent; $NF-{\kappa}B$; streptochlorin;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
Times Cited By Web Of Science : 11  (Related Records In Web of Science)
연도 인용수 순위
1 Baeuerle, P. A. and T. Henkel. 1994. Function and activation of NF-$\kappa$B in the immune system. Annu. Rev. Immunol. 12: 141-179   DOI   ScienceOn
2 Desai, S. B. and S. K. Libutti. 1999. Tumor angiogenesis and endothelial cell modulatory factors. J. Immunother. 22: 186-211   DOI
3 Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1: 27-31   DOI   ScienceOn
4 Hideshima, T., P. L. Bergsagel, W. M. Kuehl, and K. C. Anderson. 2004. Advances in biology of multiple myeloma: Clinical applications. Blood 104: 607-618   DOI   ScienceOn
5 Jung, H. J. and H. J. Kwon. 2006. Chemical genomics with natural products. J. Microbiol. Biotechnol. 16: 651-660   과학기술학회마을
6 Kim, H. J., J. H. Kim, C. H. Lee, and H. J. Kwon. 2006. Gentisyl alcohol, an antioxidant from microbial metabolite, induces angiogenesis in vitro. J. Microbiol. Biotechnol. 16: 475-479   과학기술학회마을
7 Klein, S., A. R. de Fougerolles, P. Blaikie, L. Khan, A. Pepe, C. D. Green, V. Koteliansky, and F. G. Giancotti. 2002. a5b1 integrin activates an NF-$\kappa$B-dependent program of gene expression important for angiogenesis and inflammation. Mol. Cell. Biol. 22: 5912-5922   DOI   ScienceOn
8 Ko, H. M., K. H. Seo, S. J. Han, K. Y. Ahn, I. H. Choi, G. Y. Koh, H. K. Lee, M. S. Ra, and S. Y. Im. 2002. Nuclear factor $\kappa$B dependency of platelet-activating factor-induced angiogenesis. Cancer Res. 62: 1809-1814
9 Min, J. K., Y. M. Kim, Y. M. Kim, E. C. Kim, Y. S. Gho, I. J. Kang, S. Y. Lee, Y. Y. Kong, and Y. G. Kwon. 2003. Vascular endothelial growth factor up-regulates expression of receptor activator of NF-$\kappa$B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand. J. Biol. Chem. 278: 39548-39557   DOI   ScienceOn
10 Oitzinger, W., R. Hofer-Warbinek, J. A. Schmid, Y. Koshelnick, B. R. Binder, and R. de Martin. 2001. Adenovirus-mediated expression of a mutant I$\kappa$B kinase 2 inhibits the response of endothelial cells to inflammatory stimuli. Blood 97: 1611- 1617   DOI   ScienceOn
11 Scatena, M., M. Almeida, M. L. Chaisson, N. Fausto, R. F. Nicosia, and C. M. Giachelli. 1998. NF-$\kappa$B mediates $\alpha$v$\beta$3 integrin-induced endothelial cell survival. 141: 1083-1093   DOI   ScienceOn
12 Shono, T., M. Ono, H. Izumi, S. I. Jimi, K. Matsushima, T. Okamoto, K. Kohno, and M. Kuwano. 1996. Involvement of the transcription factor NF-$\kappa$B in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol. Cell. Biol. 16: 4231-4239   DOI
13 Zakarija, A. and G. Soff. 2005. Update on angiogenesis inhibitors. Curr. Opin. Oncol. 17: 578-583   DOI   ScienceOn
14 Shin, H. J., H. S. Jeong, H.-S. Lee, S.-K. Park, H. M. Kim, and H. J. Kwon. 2007. Isolation and structure determination of streptochlorin, an anti-proliferative agent from a marinederived Streptomyces sp. 04DH110. J. Microbiol. Biotechnol. 17: 1403-1406   과학기술학회마을
15 Deplanque, G. and A. L. Harris. 2000. Anti-angiogenic agents: Clinical trial design and therapies in development. Eur. J. Cancer 36: 1713-1724   DOI   ScienceOn
16 Lim, J. K., H. J. Seo, E. O. Kim, M. Meydani, and J. D. Kim. 2006. Identification of anti-angiogenic and anti-cell adhesion materials from halophilic enterobacteria of the Trachurus japonicus. J. Microbiol. Biotechnol. 16: 1544-1553   과학기술학회마을
17 Giuliani, N., S. Colla, F. Morandi, and V. Rizzoli. 2005. Angiopoietin-1 and myeloma-induced angiogenesis. Leuk. Lymphoma 46: 29-33   DOI   ScienceOn
18 O'Reilly, M. S., T. Boehm, Y. Shing, N. Fukai, G. Vasios, W. S. Lane, E. Flynn, J. R. Birkhead, B. R. Olsen, and J. Folkman. 1997. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285   DOI   ScienceOn
19 Ingber, D., T. Fujita, S. Kishimoto, K. Sudo, T. Kanamaru, H. Brem, and J. Folkman. 1990. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348: 555-557   DOI   ScienceOn
20 Boehm, T., J. Folkman, T. Browder, and M. S. O'Reilly. 1997. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390: 404-407   DOI   ScienceOn
21 Malyankar, U. M., M. Scatena, K. L. Suchland, T. J. Yun, E. A. Clark, and C. M. Giachelli. 2000. Osteoprotegerin is an $\alpha$v$\beta$3-induced, NF-$\kappa$B-dependent survival factor for endothelial cells. J. Biol. Chem. 275: 20959-20962   DOI   ScienceOn
22 Wang, W., J. L. Abbruzzese, D. B. Evans, L. Larry, K. R. Cleary, and P. J. Chiao. 1999. The nuclear factor-$\kappa$B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin. Cancer Res. 5: 119-127
23 Kim, H. Y., J.-R. Kim, and H.-S. Kim. 2006. Synergistic effect of interleukin-18 on the expression of lipopolysaccharideinduced IP-10 (CXCL-10) mRNA in mouse peritoneal macrophages. J. Microbiol. Biotechnol. 16: 1605-1612   과학기술학회마을
24 Andersen, N. F., T. Standal, J. L. Nielsen, L. Heickendorff, M. Borset, F. B. Sorensen, and N. Abildgaard. 2005. Syndecan-1 and angiogenic cytokines in multiple myeloma: Correlation with bone marrow angiogenesis and survival. Br. J. Haematol. 128: 210-217   DOI   ScienceOn
25 Jung, H. J., H. B. Lee, C. J. Kim, J. R. Rho, J. Shin, and H. J. Kwon. 2003. Anti-angiogenic activity of terpestacin, a bicyclo sesterterpene from Embellisia chlamydospora. J. Antibiot. (Tokyo) 56: 492-496   DOI   ScienceOn
26 Watanabe, H., S. Amano, J. Yoshida, Y. Takase, S. Miyadoh, T. Sasaki, M. Hatsu, Y. Takeuchi, and Y. Komada. 1988. A new antibiotic SF2583A, 4-chloro-5-(3'-indolyl)oxazole, produced by Streptomyces. Meiji Seika Kenkyu Nenpo 27: 55-62